Aridis Pharmaceuticals Stock Filter Stocks by Fundamentals
ARDSDelisted Stock | USD 0.27 0.02 8.00% |
Aridis Pharmaceuticals fundamentals help investors to digest information that contributes to Aridis Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Aridis Pink Sheet. The fundamental analysis module provides a way to measure Aridis Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aridis Pharmaceuticals pink sheet.
Aridis |
Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
All Next | Launch Module |
Aridis Fundamentals
Return On Asset | -1.08 | ||||
Operating Margin | (9.58) % | ||||
Current Valuation | 12.11 M | ||||
Shares Outstanding | 36.21 M | ||||
Shares Owned By Insiders | 31.53 % | ||||
Shares Owned By Institutions | 11.60 % | ||||
Number Of Shares Shorted | 2 M | ||||
Price To Earning | (1.41) X | ||||
Price To Book | 5.40 X | ||||
Price To Sales | 7.33 X | ||||
Gross Profit | (22.61 M) | ||||
EBITDA | (29.51 M) | ||||
Net Income | (30.37 M) | ||||
Cash And Equivalents | 6.32 M | ||||
Cash Per Share | 0.36 X | ||||
Total Debt | 6.13 M | ||||
Debt To Equity | (0.18) % | ||||
Current Ratio | 0.41 X | ||||
Book Value Per Share | (0.77) X | ||||
Cash Flow From Operations | (29.13 M) | ||||
Short Ratio | 0.22 X | ||||
Earnings Per Share | (1.15) X | ||||
Price To Earnings To Growth | (0.02) X | ||||
Target Price | 10.0 | ||||
Number Of Employees | 37 | ||||
Beta | 0.78 | ||||
Market Capitalization | 13.24 M | ||||
Total Asset | 14.7 M | ||||
Retained Earnings | (195.67 M) | ||||
Working Capital | (25.27 M) | ||||
Current Asset | 27.39 M | ||||
Current Liabilities | 3.06 M | ||||
Z Score | -26.03 | ||||
Net Asset | 14.7 M |
About Aridis Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aridis Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aridis Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aridis Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Aridis Pink Sheet
If you are still planning to invest in Aridis Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aridis Pharmaceuticals' history and understand the potential risks before investing.
Stocks Directory Find actively traded stocks across global markets | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |